FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28394511000001105: Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
89269201000001113 Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
89269301000001116 Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Darunavir 800mg / Cobicistat 150mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has AMP Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Darunavir ethanolate true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Cobicistat false Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has specific active ingredient Cobicistat true Inferred relationship Existential restriction modifier
Rezolsta 800mg/150mg tablets (Janssen-Cilag Ltd) 30 tablet Has basis of strength substance Darunavir true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start